A genetic test known as chromosomal microarray analysis (CMA) could help identify the cause of sudden infant death syndrome (SIDS) or its counterpart in older children, known as sudden unexplained ...

A genetic test known as chromosomal microarray analysis (CMA) could help identify the cause of sudden infant death syndrome (SIDS) or its counterpart in older children, known as sudden unexplained ...

Researchers have identified pathogenic gene variations in 12% of cases of sudden unexplained death in children. The new study, which involved 116 cases of sudden infant death syndrome (SIDS) or sudden ...

A Korean research team has revealed that a new chromosomal testing method has a higher diagnostic rate than existing methods. Provided by Getty Images Bank A study has found that a diagnostic method ...

Dublin, June 30, 2025 (GLOBE NEWSWIRE) -- The "Chromosomal Microarray Market Size, Share, Trends, Analysis, and Forecast 2025-2034 | Global Industry Growth, Competitive Landscape, Opportunities, and ...

FRAMINGHAM, Mass.--(BUSINESS WIRE)--Variantyx, a leader in genomic precision medicine, today announced the launch of its IriSight™ CNV Analysis - a whole genome-based test for the detection of ...

This video explains results published in <i>NEJM</i>, which show that microarray finds significantly more clinically relevant information than the current method. Disclaimer: AAAS and EurekAlert! are ...

As DNA sequencing costs come down, the researchers want to use whole-genome sequencing to investigate SIDS, a single test that could reduce the need for CMA. Chromosomal microarray analysis (CMA) ...